These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

45 related articles for article (PubMed ID: 35184268)

  • 21. Post Hoc Analysis of the Correlation Between Patient-Reported Outcomes and Clinical Response to Repository Corticotropin Injection for Persistently Active Rheumatoid Arthritis.
    Fleischmann R; Hayes K; Ahn SW; Wan GJ; Panaccio MP; Karlsson D; Furst DE
    Rheumatol Ther; 2022 Apr; 9(2):435-446. PubMed ID: 34919213
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Repository Corticotropin Injection for Active Rheumatoid Arthritis Despite Aggressive Treatment: A Randomized Controlled Withdrawal Trial.
    Fleischmann R; Furst DE; Connolly-Strong E; Liu J; Zhu J; Brasington R
    Rheumatol Ther; 2020 Jun; 7(2):327-344. PubMed ID: 32185745
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Repository Corticotropin Injection for Persistently Active Systemic Lupus Erythematosus: Results from a Phase 4, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial.
    Askanase AD; Zhao E; Zhu J; Bilyk R; Furie RA
    Rheumatol Ther; 2020 Dec; 7(4):893-908. PubMed ID: 32996096
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Real-world treatment patterns for repository corticotropin injection in patients with rheumatoid arthritis.
    Busch H; Wan GJ; Niewoehner J; Houston P; Su Y; Clinton C; Panaccio MP
    Drugs Context; 2022; 11():. PubMed ID: 35382109
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Twenty-eight-week results from the REALISTIC phase IIIb randomized trial: efficacy, safety and predictability of response to certolizumab pegol in a diverse rheumatoid arthritis population.
    Weinblatt ME; Fleischmann R; van Vollenhoven RF; Emery P; Huizinga TW; Cutolo M; van der Heijde D; Duncan B; Davies O; Luijtens K; Dougados M
    Arthritis Res Ther; 2015 Nov; 17():325. PubMed ID: 26568428
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment patterns and achievement of the treat-to-target goals in a real-life rheumatoid arthritis patient cohort: data from 1317 patients.
    Thomas K; Lazarini A; Kaltsonoudis E; Drosos A; Papalopoulos I; Sidiropoulos P; Tsatsani P; Gazi S; Pantazi L; Boki KA; Katsimbri P; Boumpas D; Fragkiadaki K; Tektonidou M; Sfikakis PP; Karagianni K; Sakkas LI; Grika EP; Vlachoyiannopoulos PG; Evangelatos G; Iliopoulos A; Dimitroulas T; Garyfallos A; Melissaropoulos K; Georgiou P; Areti M; Georganas C; Vounotrypidis P; Kitas GD; Vassilopoulos D
    Ther Adv Musculoskelet Dis; 2020; 12():1759720X20937132. PubMed ID: 33062066
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Temporal Trends in Use of Biologic DMARDs for Rheumatoid Arthritis in the United States: A Cohort Study of Publicly and Privately Insured Patients.
    Desai RJ; Solomon DH; Jin Y; Liu J; Kim SC
    J Manag Care Spec Pharm; 2017 Aug; 23(8):809-814. PubMed ID: 28737992
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Biologic Disease-Modifying Antirheumatic Drugs in a National, Privately Insured Population: Utilization, Expenditures, and Price Trends.
    Atzinger CB; Guo JJ
    Am Health Drug Benefits; 2017 Feb; 10(1):27-36. PubMed ID: 28465766
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Post Hoc Analysis of Predictors of Clinical Response to Repository Corticotropin Injection in Persistently Active Rheumatoid Arthritis.
    Fleischmann R; Hayes K; Ahn SW; Wan GJ; Panaccio M; Karlsson D; Furst DE
    Rheumatol Ther; 2022 Apr; 9(2):649-661. PubMed ID: 35184268
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pain and Fatigue Improvements in Patients Treated with Repository Corticotropin Injection Across Five Indications: A Narrative Review.
    Girman C; Panaccio MP; Hayes K; Niewoehner J; Wan GJ
    Adv Ther; 2022 Jul; 39(7):3072-3087. PubMed ID: 35635646
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical and Economic Evaluation of Repository Corticotropin Injection: A Narrative Literature Review of Treatment Efficacy and Healthcare Resource Utilization for Seven Key Indications.
    Philbin M; Niewoehner J; Wan GJ
    Adv Ther; 2017 Aug; 34(8):1775-1790. PubMed ID: 28660550
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A Narrative Review of Repository Corticotropin Injection for the Treatment of Systemic Lupus Erythematosus.
    Askanase AD; Furie RA
    Adv Ther; 2022 Jul; 39(7):3088-3103. PubMed ID: 35641860
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Acthar Gel (RCI): A Narrative Literature Review of Clinical and Economic Evidence.
    Wan GJ; Niewoehner J; Hayes K
    Clinicoecon Outcomes Res; 2023; 15():499-512. PubMed ID: 37397803
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Assessment of the Therapeutic Effect of Total Glucosides of Peony for Juvenile Idiopathic Arthritis: A Systematic Review and Meta-Analysis.
    Cai Y; Yuan Q; Xu K; Zhu J; Li Y; Wu X; Yang L; Qiu Y; Xu P
    Evid Based Complement Alternat Med; 2016; 2016():8292486. PubMed ID: 27525026
    [TBL] [Abstract][Full Text] [Related]  

  • 35.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 36.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.